Vivo Capital

Offices: Palo Alto (United States), Beijing (China), Shanghai (China), Taipei (Taiwan), Hong Kong

Stages: Series A, Series B, Series C

Markets: Health Care, Life Sciences, Biopharma, BioTech, Medical Devices/MedTech